Literature DB >> 4392370

Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968.

J M Lane, F L Ruben, E Abrutyn, J D Millar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4392370

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  27 in total

1.  Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointment.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Eric L Simpson; Nichole E Carlson; Mark K Slifka
Journal:  Vaccine       Date:  2007-11-29       Impact factor: 3.641

Review 2.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1971-06       Impact factor: 2.401

Review 3.  Immunization today--a review.

Authors:  M I Marks; M Brazeau; R M Shapera
Journal:  Can Med Assoc J       Date:  1973-06-02       Impact factor: 8.262

4.  A selected public health bibliography with annotations.

Authors:  C M Wylie
Journal:  Am J Public Health Nations Health       Date:  1970-06

5.  Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis.

Authors:  Mark K Slifka; Donald Y M Leung; Erika Hammarlund; Hans-Peter Raué; Eric L Simpson; Susan Tofte; Shahana Baig-Lewis; Gloria David; Henry Lynn; Rob Woolson; Tissa Hata; Henry Milgrom; Jon Hanifin
Journal:  J Allergy Clin Immunol       Date:  2013-12-10       Impact factor: 10.793

6.  Lung involvement in progressive vaccinia.

Authors:  D S Chudwin; M J Cowan; D W Wara; A C Johnson
Journal:  West J Med       Date:  1981-05

Review 7.  Smallpox vaccine: the good, the bad, and the ugly.

Authors:  Edward A Belongia; Allison L Naleway
Journal:  Clin Med Res       Date:  2003-04

Review 8.  Smallpox vaccines for biodefense.

Authors:  Richard B Kennedy; Inna Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

9.  Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice.

Authors:  Henning Lauterbach; Ronny Kassub; Juliane Pätzold; Jana Körner; Michael Brückel; Admar Verschoor; Paul Chaplin; Mark Suter; Hubertus Hochrein
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

10.  A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.

Authors:  Alfred von Krempelhuber; Jens Vollmar; Rolf Pokorny; Petra Rapp; Niels Wulff; Barbara Petzold; Amanda Handley; Lyn Mateo; Henriette Siersbol; Herwig Kollaritsch; Paul Chaplin
Journal:  Vaccine       Date:  2009-11-25       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.